文献速递神经骨肌CTDSA

成人脊髓性肌萎缩症患者经图像引导鞘内注射诺西那生钠的辐射暴露

Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy.
PubMed 文献 · Neuroradiology · 2019-03-14

研究纳入2017年8月至2018年6月间14例成人脊髓性肌萎缩症(2型9例、3型5例,平均年龄33.6岁)共60次图像引导鞘内注射诺西那生钠,采用基于蒙特卡罗模拟的剂量监测程序评估诊断参考水平、可达到剂量、体型特异性剂量估计及器官和有效剂量。结果显示CT引导注射平均有效剂量为2.5 mSv(中位数2.0 mSv,四分位距1.3-3.2 mSv),作者认为尽管存在严重解剖困难,SMA患者的辐射暴露以诊断参考水平衡量通常不高于非SMA患者。

要点

  • CT剂量指数诊断参考水平56.4 mGy、可达到剂量36.7 mGy;剂量长度乘积诊断参考水平233.1 mGy cm、可达到剂量120.1 mGy cm。
  • 透视引导剂量面积乘积诊断参考水平239.1 μGy m2;体型特异性剂量估计均值9.2 mGy。
  • CT引导注射平均有效剂量2.5 mSv(中位数2.0 mSv,四分位距1.3-3.2 mSv)。

核心结论

  • 尽管SMA患者存在严重解剖困难,其辐射暴露以诊断参考水平衡量通常不高于非SMA患者;剂量监测数据可能有助于临床医生分层辐射风险、识别危及器官并采取特定辐射剂量降低措施。

研究设计与样本

  • 研究纳入2017年8月至2018年6月间60次图像引导鞘内诺西那生钠治疗,患者为14例成人SMA(2型9例、3型5例,平均年龄33.6岁,年龄范围25-57岁),采用基于蒙特卡罗模拟技术的剂量监测程序评估诊断参考水平、可达到剂量、体型特异性剂量估计及器官和有效剂量。

诊断标准与关键数值

  • CT剂量指数:诊断参考水平56.4 mGy,可达到剂量36.7 mGy。
  • 剂量长度乘积:诊断参考水平233.1 mGy cm,可达到剂量120.1 mGy cm。
  • 透视引导剂量面积乘积:诊断参考水平239.1 μGy m2,可达到剂量135.2 mGy cm2。
  • 体型特异性剂量估计均值9.2 mGy。
  • CT引导注射平均有效剂量2.5 mSv(中位数2.0 mSv,四分位距1.3-3.2 mSv)。

临床应用与阅片要点

  • 剂量监测数据可能有助于临床医生分层辐射风险、识别危及器官并采取特定辐射剂量降低措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To examine diagnostic reference levels (DRL) and achievable doses (AD) of image-guided and size-specific dose estimates (SSDE) and organ and effective doses of CT-guided intrathecal nusinersen administration to adult patients with spinal muscular atrophy (SMA).

METHODS: This study involved a total of 60 image-guided intrathecal nusinersen treatments between August 2017 and June 2018. Patient cohort comprised 14 adult patients with the following SMA types: type 2 (n = 9) and type 3 (n = 5) with a mean age of 33.6 years (age range 25-57 years). DRL, AD, SSDE, organ, and effective doses were assessed with a dose-monitoring program based on the Monte Carlo simulation techniques.

RESULTS: DRL and AD for computed tomography are summarised as follows: in terms of CT-dose index (CTDIvol), DRL 56.4 mGy and AD 36.7 mGy; in terms of dose-length product (DLP), DRL 233.1 mGy cm and AD 120.1 mGy cm. DRL and AD for fluoroscopic guidance were distributed as follows: in terms of dose-area product (DAP), DRL 239.1 μGy m2 and AD 135.2 mGy cm2. Mean SSDE was 9.2 mGy. Mean effective dose of the CT-guided injections was 2.5 mSv (median 2.0 mSv, IQR 1.3-3.2 mSv). Highest organ doses in the primary beam of radiation were the small intestine 12.9 mSv, large intestine 9.5 mSv, and ovaries 3.6 mSv.

CONCLUSION: Radiation exposure of SMA patients measured as DRLs is generally not higher compared with patients without SMA despite severe anatomical hazards. Dose monitoring data may allow clinicians to stratify radiation risk, identify organs at risk, and adopt measures for specific radiation dose reduction.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Oldenburg D, Guberina N, Stolte B, et al. Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy. Neuroradiology. 2019. PMID: 30868184. doi:10.1007/s00234-019-02189-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。